CathWorks announced the approval of a new Current Procedural Terminology (CPT) code 0523T for non-invasive, 3-D FFRangio-enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. The company said the code issuance is a major step forward in helping physicians objectively and cost-effectively determine if percutaneous coronary intervention (PCI)  is indicated and revascularization has occurred in every coronary angiography procedure.

French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new type of cardiac support to improve the management of patients with severe heart failure. The CALYPSO Research and Development (R&D) program, with a total budget of 25 million euros over 4 years, will be partially financed with 14 million euros support from the Programme d'Investissements d'Avenir (Future Investments Program), managed by the Secrétariat Général pour l’Investissement (General Secretariat for Investment – SGPI) and operated by Bpifrance.